FDA Adverse Event Injury Summary report: N

UNKNOWN COOL TIP ELECRTRODE

MDR report key: 9786516 · Received March 4, 2020

Report

Report Number
1717344-2020-00240
Event Type
Injury
Date Received
March 4, 2020
Date of Event
October 1, 2015
Report Date
March 4, 2020
Manufacturer
COVIDIEN MFG DC BOULDER
Product Code
GEI
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). TITLE RADIOFREQUENCY ABLATION OF STAGE IA NON-SMALL CELL LUNG CANCER IN MEDICALLY INOPERABLE PATIENTS: RESULTS FROM THE AMERICAN COLLEGE OF SURGEONS ONCOLOGY GROUP Z4033 (ALLIANCE) TRIAL. SOURCE CANCER, VOLUME 121, 2015(1-23) ARTICLE NUMBER: 19 DATE OF PUBLICATION: 1 OCTOBER 2015. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

ACCORDING TO THE LITERATURE STUDY PERFORMED LAST DECEMBER 2006 TO NOVEMBER 2010, IN A STUDY EVALUATED THE TWO-YEAR OVERALL SURVIVAL (OS), ADVERSE EVENT RATE, LOCAL CONTROL RATE AND IMPACT ON PULMONARY FUNCTION TESTS (PFTS) IN MEDICALLY INOPERABLE PATIENTS WITH STAGE IA NSCLC (NON-SMALL CELL LUNG CANCER) UNDERGOING CT-GUIDED RFA (RADIOFREQUENCY ABLATION) IN A PROSPECTIVE MULTI-CENTER TRIAL. 54 PATIENTS M:F=25:29, MEDIAN AGE/RANGE= 76/60-89 WERE ENROLLED FROM 16 US CENTERS 51 PATIENTS WERE ELIGIBLE (BIOPSY PROVEN STAGE IA NSCLC AND DEEMED MEDICALLY INOPERABLE BY BOARD CERTIFIED THORACIC SURGEON) FOR EVALUATION. PFTS WERE OBTAINED WITHIN 60 DAYS OF RFA, 3 AND 24 MONTHS AFTER RFA. ALL PATIENTS WERE TREATED WITH A COVIDIEN CLUSTER COOL-TIP ELECTRODE (COVIDIEN, (B)(4)) UNDER CT-GUIDANCE ACCORDING TO THE MANUFACTURER¿S SPECIFICATIONS. OUT OF 54 PATIENTS, 1 HAD PLEURAL EFFUSION REQUIRING DRAINAGE AND 1 PULMONARY INFECTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
251436 UNKNOWN COOL TIP ELECRTRODE ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES GEI COVIDIEN MFG DC BOULDER UNKNOWN COOL TIP ELECRTRODE

Patients

Seq Age Sex Outcome Treatment
1 76 YR Other